Anemia Prenatal is A Risk Factor for Postpartum Hemorrhage

ASIROTUL MA RIFAH; NANING PUII SURYANTINI

doi:10.58526/jsret.v2i3.230

Authors

ASIROTUL MA RIFAH Universitas Bina Sehat PPNI
NANING PUII SURYANTINI Universitas Bina Sehat PPNI Mojokerto

DOI:

https://doi.org/10.58526/jsret.v2i3.230

Keywords:

Anemia, Pregnancy, Postpartum Hemorrhagic (HPP)

Abstract

Postpartum Hemorrhagic is still the main cause of maternal death. While anemia is a major contributor to maternal morbidity, therefore, to prevent Postpartum Hemorrhagic (PPH), it is important to be aware of the occurrence of anemia during pregnancy. The purpose of this study was to determine the relationship between anemia in pregnancy and postpartum hemorrhagic events at the Sukodono Health Center, Sidoarjo. This research is an observational study with a cross sectional approach. The population in this study was 125 respondents, a sample of 42 respondents was obtained using purposive sampling technique. Data collection used secondary data (medical records January - December 2022). Data were analyzed using the Fisher's Exact Test statistic with a significance level of α (0.05). The results showed that the ρ-value = 0.008, meaning that ρ (0.008) < α (0.05) or H1 is accepted: there is a relationship between anemia in pregnancy and the incidence of postpartum hemorrhagic (PPH) at the Sukodono Health Center, Sidoarjo Regency. Pregnancy with anemia in the third trimester has a high risk of experiencing Postpartum Hemorrhagic, so it is necessary to increase awareness of anemia by optimizing integrated antenatal care services.

Downloads

Download data is not yet available.

References

Ambounda, N. L., Woromogo, S. H., Yagata-Moussa, F.-E., Ossouka, L. A. O., Tekem, V. N. S., Ango, E. O., & Kouanang, A. J. (2021). Primary postpartum haemorrhage at the Libreville University Hospital Centre: Epidemiological profile of women. PLoS One, 16(9), e0257544.

Auerbach, M., Landy, H. J., & Barss, V. A. (2020). Anemia in pregnancy. UpToDate.[Internet]. Recuperado a Partir de: Https://Www. Uptodate. Com/Contents/Anemia-in-Pregnancy, 1.

Corniawati, I. (2022). 9.2 Masa Nifas. Asuhan Nifas, 105.

Faysal, H., Araji, T., & Ahmadzia, H. K. (2022). Recognizing who is at risk for postpartum hemorrhage: targeting anemic women and scoring systems for clinical use. American Journal of Obstetrics & Gynecology MFM, 100745.

Fegita, P., & Satria, P. H. (2018). Hemorrhagic post partum: syok hemorrhagic ec late hemorrhagic post partum. Jurnal Kesehatan Andalas, 7, 71–75.

Güngördük, K., Olgaç, Y., Gülseren, V., & Kocaer, M. (2018). Active management of the third stage of labor: A brief overview of key issues. Turkish Journal of Obstetrics and Gynecology, 15(3), 188.

Gynecologists, A. C. of O. and. (2017). Practice bulletin no. 183: Postpartum hemorrhage. Obstet Gynecol, 130(4), e168–e186.

Kasiati, K. (2017). Usia Resiko Tinggi dan Perdarahan Post Partum. Jurnal Informasi Kesehatan Indonesia (JIKI), 3(2), 91–95.

Kemenkes, R. I. (2020a). Profil Kesehatan Indonesia Tahun 2019. Kementerian Kesehatan RI.

Kemenkes, R. I. (2020b). Profil Kesehatan Indonesia Tahun 2019 Edisi 2. Jakarta: Kementrian Kesehatan Republik Indonesia.

Manuaba. (2015). Buku Ajar Panthoom Obstetri. Jakarta Timur: Cv. Trans Info Media.

Manuaba, I. G. B., & Obstetri, P. K. (2007). EGC. Jakarta.

Notoatmodjo, S. (2018). Metode Penelitian Kesehatan, Cetakan Ke Tiga. Pt Rineka. Jakarta.

Pradana, M. A. R. A., & Asshiddiq, M. R. F. (2021). Hubungan Antara Paritas dengan Kejadian Perdarahan Post Partum. Jurnal Ilmiah Kesehatan Sandi Husada, 10(1), 326–331.

Prastika, E. P., Otok, B. W., & Purhadi, P. (2021). Pemodelan Multivariate Adaptive Generalized Poisson Regression Spline pada Kasus Jumlah Kematian Ibu di Provinsi Jawa Timur. Inferensi, 4(1), 1–12.

Shields, L. E., Goffman, D., & Caughey, A. B. (2017). Postpartum hemorrhage. Obstetrics and Gynecology, 130(4), E168–E186.

WHO. (2018). Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children, March 2018: supplement to the 2016 consolidated guidelines of the use of antiretroviral drugs for treating and preventing HI.